REFERENCES
- Bryson PD. Mercury. In Comprehensive Review in Toxicology, 2nd Ed. Bockville, Maryland: Aspen Publishers, Inc., 1989; 477–486.
- Bakri F, Damluji S, Amin-Zaki L, Murtadha M, Khalidi A, Al-Rawi NY, Tikriti S, Dahahr HJ, Clarkson TW, Smith JC, Doherty RA. Methylmercury poisoning in Iraq. Science 1973; 81:203–241.
- Ngim CH, Foo SC, Boey KW, Jeyaratnam J. Chronic neurobehavioural effects of elemental mercury in dentists. Brit J Indust Med 1992; 49; 782–790.
- Warfvinge K. Mercury distribution in the mouse brain after mercury vapour exposure. Int J Exp Pathol 1995; 76:29–35. [PUBMED], [INFOTRIEVE], [CSA]
- Cox C, Clarkson TW, Marsh DO, Amin-Zaki L, Tikriti S, Myers GG. Dose-response analysis of infants prenatally exposed to methylmercury: An application of a single compartment model to single strand hair analysis. Environ Res 1989; 49:318–332. [PUBMED], [INFOTRIEVE]
- Myes GJ, Davidson PW, Shamlaye CF. A review of methylmercury and child development. Neurotoxicology 1998; 19:313–328. [CSA]
- Sørensen N, Murata K, Budtz-Jørgensen E, Weihe P, Grandjean P. Prenatal methylmercury exposure as a cardio vascular risk factor at seven years of age. Epidemiology 1999; 10:370–375.
- Murtal K, Weihe P, Renzoni A, Debes F, Vasconcelos R, Zino F, Araki S, Jorgensen PJ, White RF, Grandjean P. Delayed evoked potentials in children exposed to methylmercury from seafood. Neurotoxicol Teratol 1999; 21:343–348. [CSA], [CROSSREF]
- Szasz A, Barna B, Szupera Z, De Visscher G, Galbacs Z, Kirsch-Volders M, Szente M. Chronic low-dose maternal exposure to methylmercury enhances epileptogenicity in developing rats. Int J Dev Neurosci 1999; 17(7):733–742. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Grandjean P, Budtz-Jorgensen E, White RF, Jorgensen PJ, Weihe P, Debes F, Keiding N. Methylmercury exposure biomarkers as indicators of neurotoxicity in children aged 7 years. Am J Epidemiol 1999; 150:301–305. [PUBMED], [INFOTRIEVE], [CSA]
- Cole HN, Schreiber N, Sollman T. Mercurial Ointment in the treatment of syphilis. Arch Dermatol 1930; 21:372–393.
- Turk JL, Baker H. Nephrotic syndrome due to ammoniated mercury. Brit J Dermatol 1968; 80:623–624.
- Marzulli FN, Brown WC. Potential systemic hazards of topically applied mercurials. J Soc Cosm Chem 1972; 23:875–886.
- Mahe A, Blanc L, Halna JM, Keita S, Sanogo T, Bobin P. An epidemiologic survey on the cosmetic use of bleaching agents by the women of Bamako (Mali). Ann Dermatol Venereol 1993; 120:870–873. [PUBMED], [INFOTRIEVE], [CSA]
- Koviakov VV, Goldfarb LUS. Acute gray mercury ointment poisoning. Anesteziologilia Ressnmatologilia 1995; 3:59–60. [CSA]
- Balluz LS, Philen RM, Sewell CM, Voorhees RE, Falter KH, Paschal D. Mercury toxicity associated with a beauty lotion, New Mexico. Int J Epidemiol 1997; 26:1131–1132. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Garza-Ocanas L, Torres-Alanis O, Pineyro-Lopez A. Urinary mercury in twelve cases of cutaneous mercurous chloride (calomel) exposure: effect of sodium 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy. J Toxicol-Clin Toxicol 1979; 35:653–655. [CSA]
- Jovanovic S, Maisner V, Horras-hu G, Garbis T, Schwenk M. Poisoning of a family by a mercury-containing ointment. Gesundheitswesen 1997; 59:405–408. [PUBMED], [INFOTRIEVE], [CSA]
- Weldon MM, Smolinski MS, Maroufi A, Hasty BW, Gilliss DL, Boulanger LL, Balluz LS, Dutton RJ. Mercury poisoning associated with a Mexican beauty cream. Western J Med 2000; 173:15–18. [CSA], [CROSSREF]
- McRill C, Boyer LV, Flood TJ, Ortega L. Mercury toxicity due to use of a cosmetic cream. J Occup Environ Med 2000; 42:4–7. [PUBMED], [INFOTRIEVE], [CSA]
- Barr RD, Woodger BM, Rees PH. Levels of mercury in urine correlate with the use of skin lightening creams. Am J Clin Patho 1973; 59:36–40.
- Bourgeois M, Dooms-Goossens A, Knockard D, Sprengers D, Van Boven M, Van Tittelboom M. Mercury intoxication after topical application of metallic mercury ointment. Dermatologica 1986; 172:48–51. [PUBMED], [INFOTRIEVE]
- Berlin M. Mercury. In: Friberg L, Nordberg GF, Vouk VL, eds. Handbook on the Toxicology of Metals. Amsterdam: Elsevier/North-Holland, 1979:503–530.
- Silverberg DS, McCall JT, Hunt JC. Nephrotic syndrome with the use of ammoniated mercury. Arch Intern Med 1967; 120:581–586. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kibuhamusohe JW, Davies DR, Hutt MSR. Membranous nephropathy due to skin lightening cream. Brit Med J 1974; 2:646–647.
- Lyons TJ, Christu CN, Larsen FS. Ammoniated mercury ointment and the nephrotic syndrome. Minnesota Med 1975; 58:383–384. [PUBMED], [INFOTRIEVE]
- Jeddeloh RJ, Lake KD, Brown DC. Ammoniated mercury membranous nephropathy. Minnesota Med 1985; 68:591–592. [PUBMED], [INFOTRIEVE]
- Oliveira DBG, Foster G, Savill J, Syme PD, Taylor A. Memberanous nephropathy caused by mercury-containing skin lightening cream. Postgrad Med J 1987; 63:303–304. [PUBMED], [INFOTRIEVE]
- FDA, Food and Drug Administration. FDA's Cosmetics Handbook. U.S. Department of Health and Human Services, Public Health Service, Food and Drug Administration. 1992.
- Al-Saleh I, El-Doush I. Mercury content in skin lightening creams and potential hazards to the health of Saudi women. J Toxicol Environ Health 1997; 51:131–148. [CROSSREF]
- Al-Saleh I, Shinwari N. Urinary mercury levels in females: influence of skin lightening creams and dental amalgam fillings. BioMetals 1997; 10:315–323. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- WHO, World Health Organization. Environmental Health Criteria 118: Inorganic mercury, WHO, Geneva. 1991.
- Rothery E. VGA-76 Vapor Generation Accessory operating manual. Varian Australia Pty. Ltd., Mulgrave, Victoria, Australia. 1989.
- Statgraphics software. Statistical graphics system by statistical graphics corporation, A PLUS* WARE software product, STSC, Inc., 1999.
- Palmer RB, Godwin DA, McKinney PE. Transdermal kinetics of a mercurous chloride beauty cream: An in vitro human skin analysis. J Toxicol-Clin Toxicol 2000; 38:701–707. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Friberg L, Skog E, Wahlberg JE. Resorption of mercuric chloride and methyl mercury dicyandiamide in guinea-pigs through normal skin and through skin pre-treated with acetone, alkylarysulphonate and soap. Acta dermatovenerologica 1961; 41:40–52.
- Skog E, Wahlberg JE. A comparative investigation of the precutaneous absorption of metal compounds in the guinea-pig by means of the radioactive isotopes: 31Cr, 36Co, 63Zn, 100mCd, 203Hg. J Invest Dermatol 1964; 43:187–192. [PUBMED], [INFOTRIEVE]
- Wahlberg JE. “Disappearance measurements”, a method for studying percutaneous absorption of isotope-labeled compounds emitting gamma-rays. Acta dermato-venereologica 1965; 45:397–414. [PUBMED], [INFOTRIEVE]
- Daian T, Namikoshi T, Fujii H. Intracellular distribution of Hg2+ applied to epidermis in mice. Analysis of subcellulr fraction. J Dermatol Sci 1995; 10:233–237. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zalups RK, Barfuss DW. Participation of mercuric conjugates of cystein, homocysteine, and N-acetylcysteine in mechanisms involved in the renal tubular uptake of inorganic mercury. J Am Soc Nephrol 1998; 9:551–561. [PUBMED], [INFOTRIEVE], [CSA]
- Freeman RB, Maher JF, Schreiner GE, Mostofi FK. Renal tubular necrosis due to nephrotoxicity of organic mercurial diuretics. Ann Intern Med 1962; 57:34–43. [PUBMED], [INFOTRIEVE]
- Giunta F, Dilandro D, Chiarmda M. Severe acute poisoning from the ingestion of a permanent wave solution of mercuric chloride. Hum Toxicol 1983; 2:243–246. [PUBMED], [INFOTRIEVE]
- Rosenman KD, Valciukas JA, Glickman L, Meyers BR, Cinotti A. Sensitive indicators of inorganic mercury toxicity. Arch Environ Health 1986; 41:208–215. [PUBMED], [INFOTRIEVE]
- Enwonwu CO. Potential health hazard of the use of mercury in dentistry: Critical review of the literature. Environ Res 1987; 42:257–274. [PUBMED], [INFOTRIEVE]
- van Ravenzwaay B, Leibold E. The significance of in vitro rat skin absorption studies to human risk assessment. Toxicol In Vitro 2004; 18(2):219–225. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Baranowska-Dutiewicz. B. Evaluation of the skin uptake of mercuric chloride in man. J Appl Toxicol 1982; 2(5):223–225.
- Spalding MG, Frederick PC, McGill HC, Bouton SN, McDowell LR. Methylmercury accumulation in tissues and its effect on growth and appetite in captive great egrets. J Widlife Dis 2000; 36:411–422.
- Khan AT, Atkinson A, Graham TC, Shireen KF. Uptake and distribution of mercury in rats after repeated administration of mercuric chloride. J Environ Sci Health. Part A 2001; 36:2039–2045.
- Davis BJ, Price HC, O'Connor RW, Fernando R, Rowland AS, Morgan DL. Mercury vapor and female reproductive toxicity. Toxicol Sci 2001; 59:291–296. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zalups RK. Autometallographic localization of inorganic mercury in the kidneys of rats: effect of unilateral nephrecomy and compensatory renal growth. Exp Mol Pathol 1991; 54:10–21. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zalups RK. Molecular interactions with mercury in the kidney. Pharmacol Rev 2000; 52:113–143. [PUBMED], [INFOTRIEVE]
- Zalups RK, Barfuss DW. Accumulation of inorganic mercury along the renal proximal tubule of the rabbit. Toxicol Appl Pharmacol 1990; 106:245–253. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sanchez DJ, Belles M, Albina ML, Sirvent JJ, Domingo JL. Nephrotoxicity of simultaneous exposure to mercury and uranium in comparison to individual effects of these metals in rats. Biol Trace Elem Res 2001; 84:139–154. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Duncan-Achanzar KB, Jones JT, Burke MF, Carter DE, Laird DE. Inorganic mecury chloride-induced apoptosis in the cultured porcine renal cell line LLC-PK1. J Pharmacol Exp Ther 1996; 277:1726–1732. [PUBMED], [INFOTRIEVE], [CSA]
- Dieter MP, Boorman GA, Jameson CW, Eustis SL, Uraih LC. Development of renal toxicity in F344 rats gavaged with mercuric chloride for 2 weeks, or 2, 4, 6, 15 and 24 months. J Toxicol Environ Health 1992; 36:319–340. [PUBMED], [INFOTRIEVE]
- Afonne OJ, Orisakwe OE, Obi E, Dioka CE, Ndubuka GI. Nephrotoxic actions of low-dose mercury in mice: protection by zinc. Arch Environ Health 2002; 37:98–102. [CSA]
- Langford NJ, Ferner RE. Toxicity of mercury. J Hum Hypertens 1999; 13:651–656. [PUBMED], [INFOTRIEVE], [CSA]
- Satoh M, Nishimura N, Kanayama Y, Naganuma A, Suzuki T, Tohyama C. Enhanced renal toxicity by inorganic mercury in metallothionein-null mice. J Pharmacol Exp Ther 1997; 283:1529–1533. [PUBMED], [INFOTRIEVE], [CSA]
- Soo YO, Chow KM, Lam CW, Lai FM, Szeto CC, Chai MH, Li PK. A whitened face woman with nephrotic syndrome. Am J Kidney Dis 2003; 41:250–253. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Morcillo MA, Santamaria J. Mercury distribution and renal metallothionein induction after subchronic oral exposure in rats. Biometals 1996; 9:213–220. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Yasutake A, Nakano A, Hirayama K. Induction by mercury compounds of brain metallothionein in rats: HgO exposure induces long-lived brain metallothionein. Arch Toxicol 1998; 72:187–191. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Alexidis AN, Rekka E, Kourounakis PN. Effect of mercury on the hepatic microsomal enzymes. Eur J Pharm Sci 1994; 2:170, [CROSSREF]
- Strubelt O, Kremer J, Tilse A, Keogh J, Pentz R, Younes M. Comparative studies on the toxicity of mercury, cadmium, and copper toward the isolated perfused rat liver. J Toxicol Environ Health 1996; 47:267–283. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Zalups RK, Barfuss DW, Lash LH. Relationship between alterations in glutathione metabolism and the deposition of inorganic mercury in rats: Effects of biliary ligation and chemically induced modulation of glutathione status. Chem Biol Interact 1999; 123:171–195. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- El-Demerdash FM. Effects of selenium and mercury on the enzymatic activities and lipid peroxidation in brain, liver, and blood of rats. J Environ Sci Health, Part B 2001; 36:489–499. [CSA]
- Jaw S, Jeffery EH. Role of metallothionein in biliary metal excretion. J Toxicol Environ Health 1989; 28:39–51. [PUBMED], [INFOTRIEVE]
- Tandon SK, Singh S, Prasad S, Mathur N. Hepatic and renal metallothionein induction by an oral equimolar dose of zinc, cadmium or mercury in mice. Fd Chem Toxicol 2001; 39:571–577. [CROSSREF]
- Lapham LW, Cernichiari E, Cox C, Myers GJ, Baggs RB, Brewer R, Shamlaye CF, Davidson PW, Clarkson TW. An analysis of autopsy brain tissue from infants prenatally exposed to methylmercury. Neurotoxicol 1995; 16:689–704. [CSA]
- Takeuchi T, Eto K, Tokunaga H. Mercury level and histopathological distribution in a human brain with Minamata disease following a long-term clinical course of twenty-six years. Neurotoxicology 1989; 10:651–657. [PUBMED], [INFOTRIEVE]
- Hua J, Brun A, Berlin M. Pathological changes in the Brown Norway rat cerebellum after mercury vapour exposure. Toxicology 1995; 104:83–90. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Warfvinge K, Brunn A. Mercury accumulation in the squirrel monkey eye after mercury vapour exposure. Toxicology 1996; 107:189–200. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Moller-Madsen B. Localization of mercury in CNS of the rat. III. Oral administration of methylmercury chloride (CH3HgCl). Fund Appl Toxicol 1991; 16:172–187. [CSA], [CROSSREF]
- Davis LE, Kornfeld M, Mooney HS, Fiedler KJ, Haaland KY, Orrison WW, Cernichiari E, Clarkson TW. Methylmercury poisoning: Long-term clinical, radiological, toxicological, and pathological studies of an affected family. Ann Neurol 1994; 35:680–688. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Boyle J, Kennedy CT. Hydroquinone concentrations in skin-lightening creams. Brit J Dermatol 1986; 114:501–504.
- David RM, English JC, Totman LC, Moyer C, O'Donoghue JL. Lack of nephrotoxicity and renal cell proliferation following subchronic dermal application of a hydroquinone cream. Fd Chem Toxicol 1998; 36:609–616. [CROSSREF]
- Zalups RK. Progressive losses of renal mass and the renal and hepatic disposition of administered inorganic mercury. Toxicol Appl Pharmacol 1995; 130:121–131. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bigazzi PE. Metals and kidney autoimmunity. Environ Health Perspect 1999; 107(Suppl 5):753–765. [PUBMED], [INFOTRIEVE], [CSA]
- Thompson SA, Roellich KL, Grossmann A, Gilbert SG, Kavanagh TJ. Alterations in immune parameters associated with low level methylmercury exposure in mice. Immunopharmacol Immunotoxicol 1998; 20:299–314. [PUBMED], [INFOTRIEVE], [CSA]
- Eto K, Yasutake A, Miyamoto K, Tokunaga H, Otsuka Y. Chronic effects of methylmercury in rats: II. Pathological aspects. Tohoku J Exp Med 1997; 182:197–205. [PUBMED], [INFOTRIEVE], [CSA]
- Eto K, Yasutake A, Korogi Y, Akima M, Shimozeki T, Tokunaga H, Kuwana T, Kaneko Y. Methylmercury poisoning in common marmosets—MRI findings and peripheral nerve lesions. Toxicol Pathol 2002; 30:723–734. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Yanagisawa H, Nodera M, Sato M, Moridaira K, Sato G, Wada O. Decreased expression of brain nitric oxide synthase in macula densa cells and glomular epithelial cells of rats with mercury chloride-induced acute renal failure. Toxicol Appl Pharmacol 2002; 184:165–171. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- NTP, National Toxicology Program. Toxicology and carcinogenesis studies of mercuric chloride (CAS No. 7487-94-7) in F344 rats and B6C3F1 mice (gavage studies). National Toxicology Program Technical Report Series 1993; 408:1–260.
- Lauwerys R, Bonnier CH, Evrard PH, Gennart PH, Bernard A. Prenatal and early postnatal intoxication by inorganic mercury resulting from the maternal use of mercury containing soap. Hum Toxicol 1987; 6:253–256. [PUBMED], [INFOTRIEVE], [CSA]
- Kuhnert PM, Kuhnert BR, Ehrard P. Comparison of mercury levels in maternal blood, fetal cord blood and placental tissues. Am J Obstet Gynecol 1981; 139:209–213. [PUBMED], [INFOTRIEVE]
- Gale TF, Ferm V. Embryopathic effects of mercuric salts. Life Sci 1971; 10:1341–1347. [CROSSREF]
- Gale TF, Hanlon DP. The permeability of the Syrian hamster placenta to mercury. Environ Res 1976; 12:26–31. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Gale TF. The embryotoxic response produced by inorganic mercury in different strains of hamsters. Environ Res 1981; 24:152–161. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Holt D, Webb M. The toxicity and teratogenicity of mercury in the pregnant rat. Arch Toxicol 1986; 58:243–248. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Thuvander A, Sundberg J, Oskarsson A. Immunomodulating effects after perinatal exposure to methylmercury in mice. Toxicology 1996; 114:163–175. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Yang J, Jiang Z, Wang Y, Qureshi IA, Wu XD. Maternal-fetal transfer of metallic mercury via the placenta and milk. Ann Clin Lab Sci 1997; 27:135–141. [PUBMED], [INFOTRIEVE]
- Takahashi Y, Tsuruta S, Hasegawa J, Kameyama Y, Yoshida M. Release of mercury from dental amalgam fillings in pregnant rate and distribution of mercury in maternal and fetal tissues. Toxicology 2001; 163:115–126. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sundberg J, Jonsson S, Karlsson MO, Oskarsson A. Lactational exposure and neonatal kinetics of methylmercury and inorganic mercury in mice. Toxicol Appl Pharmacol 1999; 154:160–169. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kim CY, Nakai K, Kasanuma Y, Satoh H. Comparison of neurobehavioral changes in three inbred strains of mice prenatally exposed to methylmercury. Neurotoxicol Teratol 2000; 22:397–403. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lewandowski TA, Pierce CH, Pingree SD, Hong S, Faustman EM. Methylmercury distribution in the pregnant rats and embryo during early midbrain organogenesis. Teratology 2002; 66:235–241. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Morgan DL, Chanda SM, Price HC, Fernando R, Liu J, Brambila E, O'Conner RW, Beliles RP, Barone S Jr. Disposition of inhaled mercury vapor in pregnant rats: Maternal toxicity and effects on developmental outcome. Toxicol Sci 2002; 66:261–273. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Yoshida M. Placental to fetal transfer of mercury and fetotoxicity. Tohoku J Exp Med 2002; 196:79–88. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]